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The mechanism of gamma interferon (IFN-) production induced by listeriolysin O (LLO), a cytolytic
virulence factor of Listeria monocytogenes, was analyzed with special reference to the involvement of macro-
phage-derived cytokines in spleen cells of mice. LLO purified from the culture supernatant of L. monocytogenes
was capable of inducing a high level of IFN- when its cytolytic activity was blocked by cholesterol treatment.
The IFN--inducing ability of LLO was not dependent on possibly contaminating lipopolysaccharide. Deple-
tion of CD11b cells resulted in a profound decrease in IFN- production in response to LLO stimulation.
Negative selection also suggested the contribution of DX5 cells in IFN- production. Reverse transcription-
PCR revealed that expression of interleukin-12 (IL-12) p35 and p40 was induced by LLO but that the IL-18
mRNA level in the CD11b fraction of spleen cells was unchanged. There was no change in the expression of
the IFN--inducing cytokine genes in the CD11b fraction. Neutralization of IL-12 and IL-18 in culture
abolished the IFN- production almost completely. Spleen cells from IL-12- or IL-18-deficient mice never
produced IFN- after stimulation with LLO. These results clearly indicated that LLO, a well-known virulence
factor of L. monocytogenes, is capable of inducing IFN- from NK cells through induction of IL-12 and IL-18
from macrophages. LLO appeared to play essential roles, not only as a bacterial virulence factor but also as
a bacterial modulin in the immune response of the host.
Listeria monocytogenes is a gram-positive pathogenic bacte-
rium responsible for serious infection in immunocompromised
individuals and pregnant women (8, 10). The virulence of this
bacterium can be attributed to intracellular parasitism subse-
quent to the entry into host phagocytes. L. monocytogenes is
able to escape from the phagosome into host cell cytosol (28,
33). Escape from the phagosome is largely mediated by lis-
teriolysin O (LLO), the essential determinant of pathogenicity
(6, 19, 29).
LLO is a 56-kDa protein encoded by the hly gene, which is
located in the virulence gene cluster of the L. monocytogenes
chromosome (28). LLO is a member of a large family of thiol-
activated, cholesterol-binding, pore-forming cytolysins, includ-
ing streptolysin O (SLO), perfringolysin (PFO), and pneumo-
lysin, produced by gram-positive bacteria Streptococcus
pyogenes, Clostridium perfringens, and Streptococcus pneu-
moniae, respectively (2, 22, 31). It has been revealed that LLO
is the major virulence factor of L. monocytogenes, because an
LLO-negative mutant strain (mutant hly) did not show the
ability for intracellular growth and was completely nonvirulent
in mice (6, 21). Moreover, expression of LLO, PFO, or SLO in
Bacillus subtilis resulted in escape from the phagosome and
subsequent growth of the bacteria in the cytosol (4, 30).
In the experimental infection of mice with L. monocytogenes,
it has been shown that various inflammatory cytokines includ-
ing interleukin-1 (IL-1) (14), IL-6 (17, 18), tumor necrosis
factor alpha (TNF-) (13, 23), IL-12 (35), and gamma inter-
feron (IFN-) (24) are expressed at the early phase of infection
and play important roles in host defense. Among these cyto-
kines, the pivotal role of IFN- in the defense of mice against
primary infection has been well documented, since antilisterial
resistance was enhanced by in vivo administration of recombi-
nant IFN- (5) and inhibited by administration of an anti-
IFN- antibody (24) or in mice that do not produce IFN- (12)
and that lack the IFN- receptor (7).
It appears that various components of L. monocytogenes are
involved in IFN- induction in the infected host. In our previ-
ous study, the expression of endogenous IFN- was observed
at the initial stage only after infection with a virulent strain, not
after infection with an avirulent strain not producing LLO
(37), suggesting that LLO directly contributes to cytokine pro-
duction. In fact, we have observed that the production of IL-1
was induced by purified LLO in thioglycolate-elicited perito-
neal macrophages (36, 39) and that IFN- production was
induced in spleen cells after stimulation with purified LLO or
viable bacteria (25, 37). These findings strongly suggested that
LLO plays an essential role not only as a bacterial virulence
factor but also as a bacterial modulin in the cyokine response
of the infected host.
In the present study, we analyzed the mechanism of LLO-
induced IFN- production in spleen cells in vitro with special
reference to macrophage-derived cytokines.
MATERIALS AND METHODS
Experimental animals. Female C3H/HeN and C57BL/6 mice (Japan SLC,
Hamamatsu, Japan), raised and maintained under specific-pathogen-free condi-
tions, were used at 7 to 9 weeks of age. IL-12-deficient (IL-12 KO) and IL-18-
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deficient (IL-18 KO) mice were kindly provided by H. Okamura (Hyogo Medical
Collage, Nishinomiya, Japan) and K. Kawakami (University of the Ryukyus,
Nishihara, Japan), respectively.
Bacterial strains and growth condition. L. monocytogenes EGD, a virulent
strain, was used throughout the study. The bacteria were grown in brain heart
infusion (BHI) broth (Difco Laboratories, Detroit, Mich.) at 37°C for 7 h,
washed repeatedly, suspended in phosphate-buffered saline (PBS) with 10%
[wt/vol] glycerol, and stored at 80°C in small aliquots until used.
Reagents. Gentamicin reagent solution was purchased from Gibco-BRL Life
Technologies Inc. (Rockville, Md.). Lipopolysaccaride (LPS) derived from Esch-
erichia coli O55:B5 was purchased from Difco Laboratories. Polymyxin B was
purchased from Nacalai Tesque (Kyoto, Japan). The cytokine-specific neutral-
izing antibodies for IL-1 (rat, 40508.11), IL-1 (rat, 30311.11), IL-12 p70 (goat,
polyclonal), and TNF- (goat, polyclonal) were purchased from Genzyme/
Techne (Minneapolis, Minn.). The IL-18-specific neutralizing antibody (rat, 93-
10C) was purchased from Medical & Biological Laboratories (Nagoya, Japan).
As control antibodies, normal rat immunoglobulin (IgG) (Santa Cruz Biotech-
nology, Inc., Santa Cruz, Calif.) and normal goat IgG (Genzyme/Techne) were
used. A mouse anti-LLO monoclonal antibody (7D10.E12) was established in
our laboratory by fusion of NS-1 cells and spleen cells from mice hyperimmu-
nized with purified LLO. The specificity of the hybridoma culture supernatant
for LLO has been confirmed by the absence of reactivity to the culture super-
natants from a number of nonhemolytic strains of listeriae.
Purification of LLO. LLO was purified according to the method of Kayal et al.
(15) with some modifications. In brief, 40 ml of overnight culture of L. mono-
cytogenes was inoculated into 2 liters of fresh BHI broth, and the bacteria were
cultured for 4 h. Bacteria were harvested by centrifugation, washed once with
RPMI 1640 medium (Gibco-BRL), and transferred to 500 ml of RPMI 1640
medium. After incubation at 37°C for 2.5 h, the supernatant was collected and
concentrated by ultrafiltration using Ultra Free-15 filter units (cutoff value, 30
kDa; Millipore, Bedford, Mass.). The concentrated supernatant was passed
through a PD-10 column which had been equilibrated with 20 mM bis-Tris
propane (Nacalai Tesque), pH 6.7, and loaded on a DEAE-Sephadex column
(Amersham Pharmacia Biotech, Buckinghamshire, United Kingdom) equili-
brated at pH 6.7. The effluent fractions were pooled and used as LLO. The purity
of the fraction was determined by sodium dodecyl sulfate–10% polyacrylamide
gel electrophoresis (SDS–10% PAGE) analysis and Western blotting using an
anti-LLO monoclonal antibody. The level of contaminating endotoxin was mon-
itored by a Limulus color KY test (Wako Pure Chemical, Osaka, Japan). To
inhibit the cytolytic activity, LLO (500 nM) was treated with 10 g of cholester-
ol/ml for 30 min on ice. In some experiments, LLO was heated at 94°C for 15 min
and the hemolytic and IFN--inducing activities were assayed.
Hemolytic activity. Hemolytic activity was measured by hemoglobin release
from sheep erythrocytes (SRBC) as described previously (3). LLO was twofold
diluted with PBS and incubated with an equal volume of 1% SRBC for 30 min
at 37°C. The supernatant was collected, and the degree of hemolysis was evalu-
ated by measuring the absorbance of hemoglobin (415 nm) released from SRBC.
One hemolytic unit was defined as the amount of the toxin required for 50%
hemolysis.
Cell preparation. Spleens were aseptically removed from 3 to 7 normal mice
and squeezed between two microslide glasses to prepare the single-cell suspen-
sion. Cells were pooled and treated with 0.83% ammonium chloride in 170 mM
Tris-HCl (pH 7.65) to lyse erythrocytes. Cells were washed with RPMI 1640 and
suspended at 5  106 cells/ml in culture medium consisting of RPMI 1640, 10%
heat-inactivated fetal bovine serum (Gibco-BRL), and gentamicin (5 g/ml).
To deplete NK cells, macrophages, and dendritic cells (DCs) from whole
spleen cells, cells were suspended at 5  107 cells/ml in PBS containing 0.5%
bovine serum albumin and 2 mM EDTA and treated with anti-NK (DX5)
MicroBeads (Miltenyi Biotec, Gladbach, Germany), anti-CD11b (Mac-1) Mi-
croBeads, and anti-CD11c MicroBeads, respectively. After incubation for 15 min
at 5°C, cells were washed and the cell populations were depleted by magnetic cell
sorting (MACS) system with an LD depletion column (Miltenyi Biotec) accord-
ing to the manufacturer’s instructions. The recovered cells were suspended at 5
 106 cells/ml in culture medium. To isolate macrophages, spleen cells treated
with anti-CD11b (Mac-1) MicroBeads were passed and CD11b cells were
eluted from an MACS LS separation column (Miltenyi Biotec). The recovered
cells were suspended at 2.5  106 cells/ml in culture medium. The purity of a
negatively or positively selected cell population, i.e., the degree to which spleen
cells had been removed, was assessed by fluorescence-activated cell sorter anal-
ysis (BD PharMingen, San Diego, Calif.) by using a secondary antibody conju-
gated with fluorescein isothiocyanate (BD PharMingen). The levels of depletion
for DX5 cells, CD11b cells, and CD11c cells were 85 (2.1% before depletion
to 0.3% after depletion), 99 (10.3 to 0.1%), and 90% (3.0 to 0.3%), respectively.
LLO-induced IFN- production. Spleen cells were plated in a 96-well tissue
culture plate at 106 cells/well and stimulated for 24 h with various doses of LLO
which had been treated with or without cholesterol. The supernatant was col-
lected, and the concentration of IFN- was measured. In some experiments, cells
were stimulated with LLO in the presence of antibodies (5 g/ml) against various
kinds of cytokines including IL-1, IL-1, IL-12 p70, IL-18, and TNF- and the
effects on IFN- production were determined.
The concentration of IFN- was determined by a sandwich enzyme-linked
immunosorbent assay (ELISA) using a combination of nonlabeled and biotin-
labeled rat anti-mouse IFN- monoclonal antibodies (XMG1.2; Endogen,
Woburn, Mass.).
Reverse transcription-PCR (RT-PCR) for cytokine mRNA. Cells were plated
in a 24-well tissue culture plate at 2.5  106 cells/well and stimulated for 6 h with
50 nM LLO which had been treated with cholesterol. Total cellular RNA was
extracted with an RNeasy Mini Kit (Qiagen Inc., Valencia, Calif.), and cDNA
was reverse transcribed from 0.2 g of total RNA using a random primer as
previously described (38). PCR was performed by using KOD-plus DNA poly-
merase (TOYOBO, Osaka, Japan) and specific primer sets for cytokines. The
sequences of primers for each cytokine and the sizes of PCR products are shown
in Table 1.
The PCR cycle consisted of 94°C for 15 s, 55°C for 30 s, and 68°C for 60 s.
Samples were amplified for 23 to 33 cycles. The most appropriate number of
amplification cycles for each cytokine was determined by preliminary experi-
ments. The reaction was terminated by heating at 68°C for 7 min. The PCR
product (5 l) was electrophoresed on a 2% agarose gel and stained with
ethidium bromide. The bands of the PCR product were visualized on a UV
transilluminator.
Statistical analysis. The statistical significance of the data was determined by
Student’s t test, and a P value of 0.05 was taken as significant.
RESULTS
Purification of LLO and hemolytic activity. To enrich LLO
in the starting sample for purification, L. monocytogenes grown
TABLE 1. Primer sequences and the sizes of PCR products
Cytokine and
oligonucleotide Sequence (5	–3	)
Product
size (bp)
IFN-
Sense AGCGGCTGACTGAACTCAGATTGTAG 244
Antisense GTCACAGTTTTCAGCTGTATAGGG
IL-1
Sense CTCTAGAGCACCATGCTACAGAC 309
Antisense TGGAATCCAGGGGAAACACTG
IL-6
Sense TGGAGTCACAGAAGGAGTGGCTAAG 155
Antisense GCAAGAGACACAGTCCTGGG
IL-12 p35
Sense CTGCATCAGCTCATCGATGG 618
Antisense CAGAAGCTAACCATCTCCTGGTTT
IL-12 p40
Sense TCCGGAGTAATTTGGTGCTTCACA 396
Antisense ACTGTACAACCGCAGTAATACGG
IL-18
Sense ACTGTACAACCGCAGTAATACGG 546
Antisense AGTGAACATTACAGATTTATCCC
TNF
Sense GGCAGGTCTACTTTGGAGTCATTGC 308
Antisense ACATTCGAGGCTCCAGTGAATTCCA
-actin
Sense TGGAATCCTGTGGCATCCATGAAAC 349
Antisense TAAAACGCAGCTCAGTAACAGTCCG
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in BHI broth was washed and transferred to RPMI 1640 me-
dium. Bacteria were allowed to release LLO in RPMI medium,
and then the medium was concentrated by ultrafiltration. SDS-
PAGE analysis revealed that LLO was enriched in the concen-
trated medium (Fig. 1A, lane 1). Then buffer was replaced with
20 mM bis-Tris propane adjusted to pH 6.7, the isoelectric
point of LLO (Fig. 1A, lane 2), and the fraction passed through
a DEAE-Sephadex column was recovered as an LLO prepa-
ration. Purified LLO gave a single band with an approximate
molecular mass of 56 kDa (Fig. 1A, lane 3), which was consis-
tent with the reported molecular weight for LLO (11, 20). The
purified LLO was detected also as a single band by immuno-
blotting using an anti-LLO monoclonal antibody (Fig. 1B).
Densitometric analysis showed that the purity of this prepara-
tion was approximately 95%. It is known that the hemolytic
activity of thiol-activated cytolysins is enhanced by treatment
with a reducing agent (1). However, the purified LLO ap-
peared to have been recovered in a fully activated form be-
cause the hemolytic activity was not altered in the presence or
absence of reducing agents. The relative hemolytic activity of
this preparation was determined to be approximately 50,000
hemolytic units/mg.
The hemolytic activity of LLO was completely blocked by
pretreatment with a small amount of cholesterol or by heating
at 94°C for 15 min (Fig. 2A). The hemolytic activity of our LLO
preparation was also stable at a pH lower than 6.7 at 37°C
(data not shown), which was consistent with the previous re-
port that acidic pH was optimal for the hemolytic activity of
LLO (11).
Cytolytic and IFN--inducing activities of purified LLO.
When spleen cells were stimulated with LLO pretreated with
cholesterol, a high level of IFN- was produced in the culture
supernatant in a dose-dependent manner (Fig. 2B). The ab-
sence of IFN--inducing activity in an LLO sample not treated
cholesterol appears to be due to the high level of cytolytic
activity. The level of contaminating LPS in this preparation was
50 pg per mg of protein. This small amount of LPS in the LLO
preparation did not seem to be involved in the cytokine pro-
duction. As expected, LLO-induced production of IFN- was
not affected, even in the presence of 0.5 g of polymyxin B/ml,
which completely abolished IFN- production from spleen
cells stimulated with 1,000 pg of LPS/ml. Furthermore, the
IFN--inducing ability of LLO was impaired by heating at 94°C
for 15 min, while LPS-induced IFN- production was not (Fig.
3). These results indicated that the IFN--inducing activity was
not attributable to a small amount of LPS in the LLO prepa-
ration.
Involvement of various populations of cells in LLO-induced
IFN- production. In our previous report, NK cells and mac-
rophages were shown to be necessary for LLO-induced IFN-
production by negative selection using an antiasialo GM1 an-
tibody and a Sephadex G-10 column (25). Again, to determine
the role of NK cells, macrophages, and also DCs in LLO-
induced IFN- production, we depleted each population of
cells by using the MACS system and MicroBeads conjugated
with antibodies for DX5 (NK cells), CD11b (mainly macro-
phages), and CD11c (mainly DCs). Negatively selected cells
were stimulated with 20 nM LLO pretreated with cholesterol
for 24 h, and the titer of IFN- in the culture supernatant was
determined. After depletion of DX5 or CD11c cells, the
LLO-induced IFN- production was decreased significantly
(Fig. 4). In repeated experiments, DX5 or CD11c cells were
depleted at efficiencies of at most 90%; however, the reduction
FIG. 1. Purification of LLO from culture supernatant of L. mono-
cytogenes EGD. (A) Pattern of silver staining after SDS-PAGE of
concentrated supernatant from a 2.5-h culture in RPMI 1640 (lane 1),
the fraction in which the buffer was exchanged by passage through a
PD-10 column (lane 2), and the effluent fraction from a DEAE-Seph-
adex column (lane 3). Positions of molecular mass markers are indi-
cated on the left. (B) Immunoblot analysis of LLO. The effluent frac-
tion of a DEAE-Sephadex column was subjected to SDS-PAGE and
immunoblotting to identify the LLO molecule by using an anti-LLO
monoclonal antibody.
FIG. 2. Hemolytic and IFN--inducing activities of purified LLO.
(A) LLO (500 nM) was treated without (open circle) or with choles-
terol (10 g/ml; solid circle) or with heating at 94°C for 15 min (open
square). The samples were diluted and mixed with 1% SRBC. The
suspension was incubated for 30 min, and the percent release of he-
moglobin (Hb) was measured. (B) Spleen cells (106 cells) were stim-
ulated with LLO samples which had been treated as described above.
The level of IFN- production was determined by ELISA. Shown is a
representative result of three similar experiments. Data are means 

standard errors for three determinations.
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in IFN- response suggested the involvement of both types of
cells. CD11b cells could be eliminated almost completely by
anti-CD11b MicroBeads, and the IFN- production in re-
sponse to LLO was lost completely (Fig. 4).
LLO-induced cytokine gene expression in macrophages.
The above result indicated that CD11b cells, mainly macro-
phages, were essential for IFN- production from spleen cells
stimulated with LLO. In the next experiment, we prepared
whole spleen cells, spleen cells depleted of CD11b, and posi-
tively selected CD11b cells using MACS. Positive selection of
CD11b cells by MACS resulted in enrichment from 10.3% in
the whole spleen cells to 86.7% in the preparation of CD11b
cells according to the profile of fluorescence-activated cell
sorter analysis. Each cell population was stimulated with LLO
pretreated with cholesterol for 6 h. The total cellular RNA was
extracted, and cytokine-specific mRNA expression was exam-
ined by RT-PCR (Fig. 5). When whole spleen cells were stim-
ulated with LLO, and expression of IFN-, IL-1, IL-6, IL-10,
IL-12 p35, IL-12 p40, and TNF- mRNAs was induced. The
expression of IL-18 mRNA appeared to be constant irrespec-
tive of stimulation with LLO. When CD11b cells were stim-
ulated with LLO, expression of the genes of most of the cyto-
kines was not induced. The expression of IL-12 p35 mRNA was
shown to be constitutive, but IL-12 p40 mRNA expression was
not detected even after stimulation with LLO. In contrast,
expression of the mRNA of all cytokines, except for IFN-,
could be observed in CD11b cells after stimulation with LLO.
Expression of both IL-12 p35 mRNA and IL-12 p40 mRNA
was induced in CD11b cells. These results indicated that both
CD11b and CD11b cells are required for LLO-induced
IFN- production. It was also suggested that CD11b cells
were capable of producing biologically active IL-12 along with
the constitutive production of IL-18. These two cytokines from
CD11b cells appeared to be important for the final induction
of IFN- in spleen cells.
LLO-induced IFN- production from spleen cells treated
with a cytokine-specific neutralizing antibody. To determine
the role of cytokines derived from CD11b cells in LLO-
induced IFN- production, we examined the effect of neutral-
izing antibodies for each cytokine. After stimulation with 20
nM LLO treated with cholesterol in the presence of 5 g of a
cytokine-specific antibody/ml for 24 h, the titer of IFN- in
culture supernatant was determined by ELISA. When anti-
IL-12 p70 and/or anti-IL-18 antibodies were added, LLO-in-
duced IFN- production was significantly affected, whereas
other antibodies against IL-1, IL-1, and TNF- had no ef-
fect on LLO-induced IFN- production (Fig. 6).
LLO-induced IFN- production by spleen cells from IL-12
KO and IL-18 KO mice. To confirm the involvement of IL-12
and IL-18 in LLO-induced IFN- production, we employed
IL-12 KO and IL-18 KO mice. Spleen cells prepared from
wild-type, IL-12 KO, and IL-18 KO mice from the same
FIG. 3. Effect of polymyxin B (PMB) and heating on IFN--induc-
ing activity of LLO and LPS. Spleen cells were stimulated with cho-
lesterol-pretreated LLO (20 nM) or LPS (1 ng/ml) for 24 h, and the
level of IFN- was determined by ELISA. The effects of the addition
of 0.5 g of PMB/ml and heating at 94°C for 15 min were examined.
Shown is a representative result of two similar experiments. Data are
means 
 standard errors for three determinations. , significant dif-
ference from untreated group (P  0.01).
FIG. 4. Determination of cell populations required for LLO-in-
duced IFN- production. Spleen cells were treated with anti-NK
(DX5) MicroBeads, anti-CD11b (Mac-1) MicroBeads, or anti-CD11c
MicroBeads, followed by depletion of the cells bound to beads by using
an MACS LS separation column. The negatively selected cells were
adjusted to 5  106 cells/ml and stimulated with 20 nM LLO pre-
treated with cholesterol for 24 h. The level of IFN- was determined by
ELISA. Shown is a representative result of three similar experiments.
Data are means 
 standard errors for three determinations. , signif-
icant difference from untreated group (P  0.01). M, macrophage.
FIG. 5. Expression of mRNA for various cytokines after stimula-
tion with LLO. Whole spleen cells, CD11b cells, and CD11b cells
were stimulated with 50 nM cholesterol-pretreated LLO for 6 h. Total
RNA was extracted and subjected to RT-PCR for detection of cyto-
kine mRNA for IFN-, IL-1, IL-6, IL-12 p35, IL-12 p40, IL-18,
TNF-, and -actin. Shown is a representative result of two similar
experiments.
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C57BL/6 background were stimulated with LLO pretreated
with cholesterol. Then, the titer of IFN- in culture superna-
tant was determined. In spleen cells from both groups of KO
mice, the level of IFN- production induced by LLO was sig-
nificantly lower than that observed in the wild type (Fig. 7).
This result provided evidence that both IL-12 and IL-18 were
essential for IFN- production in response to LLO.
DISCUSSION
In a series of experiments, we have reported that LLO, the
major virulence factor of L. monocytogenes, is highly capable of
inducing various cytokines including IFN- in mice both in vivo
and in vitro (25, 36, 37, 39). LLO secreted by viable L. mono-
cytogenes appeared to play an important role in the induction
of IFN-, which is essential for the primary defense of the
infected host.
In this study, we purified LLO from culture supernatant of
L. monocytogenes to examine the mechanism of IFN- induc-
tion by LLO in spleen cells. LLO purified in this study has been
recovered in a fully active form even in the absence of a
reducing agent, and the LLO preparation was highly toxic to
the cells. When cytolytic LLO was applied to spleen cells with-
out cholesterol treatment, there was no IFN- production in-
duced. Therefore, we had to block the membrane-damaging
activity by treatment with cholesterol prior to the assay. After
stimulation with purified LLO pretreated with cholesterol,
spleen cells produced a high level of IFN- (Fig. 2). This may
occur in an in vivo situation because serum contains choles-
terol and there is a possibility that the LLO bound to the
phagosomal membrane containing cholesterol becomes a mol-
ecule similar to that obtained by cholesterol treatment.
Though LLO preparation showed a purity above 98% after
silver staining, the possibility of IFN- induction by a contam-
inating substance should be ruled out. From the results on the
effect of polymyxin B and heating, we could rule out the pos-
sible contribution of contaminating LPS (Fig. 3). In a previous
study, we reported that the culture supernatant from a strain of
L. monocytogenes not producing LLO was not capable of in-
ducing IFN- (25). Therefore, it is unlikely that IFN- induc-
tion in this study totally depends on some bacterial product
other than LLO.
We examined the role of the cell population in LLO-induced
IFN- production. DX5 cells (mainly NK cells) appeared to
be the source of IFN- in LLO-induced IFN- production by
spleen cells because the level of IFN- in the culture superna-
tants was decreased significantly when this population was
eliminated. This result was consistent with previous reports
demonstrating that NK cells produced IFN- in response to
IL-12 induced at the early phase of L. monocytogenes infection
(35). However, the level of IFN- in the culture supernatant
was decreased to the basal level when CD11b cells were
depleted. These results strongly suggested that not only IFN-
-producing cells, including NK cells, but also CD11b cells
(mainly macrophages) were required for LLO-induced IFN-
production. Recently, Ohteki et al. reported that DCs pro-
duced IFN- in response to IL-12, which was produced by DCs
themselves at an initial stage of L. monocytogenes infection
(26). Because the IFN- production was not completely inhib-
ited by depletion of either DX5 cells or CD11c cells (Fig. 4),
it appeared that DCs as well as NK cells are the source of
IFN-. It remains to be determined whether DCs produce
IL-12 and IL-18 in response to LLO. Moreover, it was shown
that both IL-12 and IL-18 are important in LLO-induced
IFN- production by spleen cells because the level of IFN- in
the culture supernatants decreased significantly when these
cytokines were neutralized by addition of cytokine-specific
neutralizing antibodies (Fig. 6). Convincing support for the
result of this assay using neutralizing antibodies was provided
by the use of IL-12 KO and IL-18 KO mice (Fig. 7). It is
unlikely that NK cells were stimulated directly with LLO for
induction of IFN-, and IFN- production appeared to be
induced in response to these cytokines from macrophages
stimulated with LLO. We confirmed that small amounts of
FIG. 6. Effect of neutralization of various cytokines on IFN- pro-
duction after stimulation with LLO. Spleen cells were stimulated with
20 nM cholesterol-pretreated LLO in the absence or presence of an
antibody specific for IL-1, IL-1, TNF-, IL-12 p70, or IL-18. The
level of IFN- was determined by ELISA. Shown is a representative
result of two similar experiments. Data are means 
 standard errors
for three determinations. , significant difference from untreated
group (P  0.01).
FIG. 7. IFN- production after stimulation of cells from IL-12 and
IL-18 KO mice with LLO. The spleen cell suspension was prepared
from C57BL/6 wild-type, IL-12 KO, and IL-18 KO mice and was
stimulated with 20 nM cholesterol-pretreated LLO for 24 h. The level
of IFN- was determined by ELISA. Shown is a representative result
of two similar experiments. Data are means 
 standard errors for
three determinations. , significant difference from wild type (P 
0.01).
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IL-12 and IL-18 could synergistically induce IFN- production
by NK cells isolated from spleen cells (data not shown).
We compared the production of IL-12 and IL-18 in response
to LLO by CD11b cells with that by CD11b cells. The
expression of these cytokines by CD11b cells isolated from
spleen cells, except for IL-18, was strongly enhanced after
stimulation with LLO (Fig. 5). In contrast, the CD11b cell
population showed a constitutive expression of IL-12 p35
mRNA but the expression of other cytokine mRNAs, including
those of IL-12 p40 and IL-18, was diminished even in the
presence of LLO, compared to those expressed by whole
spleen cells stimulated with LLO in Fig. 5. These results clearly
indicated that, in spleen cells stimulated with LLO, only
CD11b cells (mainly macrophages) were able to produce
both biologically active IL-12 p70 and IL-18, which were indis-
pensable for LLO-induced IFN- production.
The expression of IL-18 mRNA in splenic CD11b cells was
constitutive, but there was no expression in the CD11b cell
population. In mice infected with L. monocytogenes, the ex-
pression of IL-18 mRNA appeared to be constitutive in the
spleen (data not shown). It was reported that PU.1, a tran-
scription factor expressed exclusively by myeloid cells and B
cells, was involved in the constitutive expression of IL-18
mRNA in RAW264.7 cells (16). These observations, taken
together, led to the suggestion that the constitutive expression
of IL-18 mRNA in spleen cells was attributable to macro-
phages. However, the expression of IL-18 by splenic CD11b
cells was not affected by stimulation with LLO, whereas the
neutralizing antibody to IL-18 affected LLO-induced IFN-
production by spleen cells. A possible explanation is that LLO
may increase IL-18 production by increasing cleavage of pro-
IL-18 to the mature form by activating caspase-1 as well as LPS
(32).
LLO was shown to be capable of inducing the expression of
various cytokine genes, including IL-1, IL-6, IL-10, IL-12 p35,
IL-12 p40, and TNF- genes, by CD11b cells. According to
several reports on the promoter analysis of these cytokine
genes, the activation of NF-B, a transcription factor, was
required for the expression of IL-12 p35 (34), IL-12 p40 (27,
34), and TNF- (9) by stimulation with microbial components.
Though the signaling pathway for LLO to induce an IL-12
response in CD11b cells has not yet been determined, it is
probable that LLO activates NF-B, because we have observed
in a preliminary study that the induction of IL-12 p40 expres-
sion by stimulation with LLO was prevented by treatment with
MG132, an inhibitor of the degradation of IB (K. Tsuchiya,
unpublished data). Furthermore, Kayal et al. reported that
LLO induces up-regulation of adhesion molecules and chemo-
kines on endothelial cells via activation of NF-B (15).
In this study, we showed that purified LLO could induce the
expression of various cytokine genes by CD11b cells in vitro.
Among the cytokines, it became clear that IL-12 and IL-18 play
an essential role in IFN- induction by spleen cells stimulated
with LLO. While various cell wall components are known to be
highly capable of inducing cytokines, little is known about the
potential activity of protein toxins. The present results may
have provided the details of a novel aspect of LLO as the
possible ligand for stimulating innate immunity.
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